Portfolio company
Denovo Sciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
4 investors
Sectors
About
This company develops an AI-driven platform for structure-based drug discovery to provide small-molecule candidates for pharmaceutical and biotechnology organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Molecule One
This company develops an artificial intelligence platform for chemical synthesis planning and molecule discovery for pharmaceutical and biotechnology organisations.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Genesis Molecular AI
The company develops an artificial intelligence platform for molecular drug discovery to assist pharmaceutical firms in designing and optimising small molecule medicines.
CrystalsFirst GmbH
This company provides structural biology and AI-driven drug discovery services to pharmaceutical and biotechnology organisations for small-molecule development.
Variational AI
The company develops a generative artificial intelligence platform for small molecule drug discovery for biopharmaceutical and biotechnology organisations.
Anagenex
This company develops a machine learning and biochemistry platform to identify and optimise small molecule drug candidates for pharmaceutical and biotechnology organisations.
Avicenna Biosciences
The company develops a machine learning platform to optimise small molecule drug discovery and lead-to-candidate processes for biotechnology and pharmaceutical organisations.
DeepMirror AI
This company provides a drug design platform that uses machine learning to help medicinal chemists identify and optimise molecules for biopharmaceutical research.
